Emerging Infectious Disease ISSN: 1080-6059
Volume 7, Number 6—December 2001
Dispatch
Vancomycin-Intermediate Staphylococcus aureus in a Home Health-Care Patient
Figure 2

Figure 2. Pulsed-field gel electrophoresis profiles of SmaI digested DNA. NCTC, National Collection of Type Cultures 8325 control. Lane 1, vancomycin-intermediate Staphylococcus aureus (VISA) isolate from Japan, otherwise designated Mu50; lane 2, VISA isolate from Michigan (7); lane 3, VISA isolate from New Jersey (7); Lane 4, VISA isolate from New York (1); lane 5, VISA isolate from Illinois (3); lane 7, patient's oxacillin-resistant VISA; lane 8, patient's oxacillin-susceptible VISA; lane 9 patient's oxacillin-resistant S. aureus (ORSA, vancomycin MIC = 2 µg/mL) from anterior nares; lanes 10 and 11, isolates of ORSA (vancomycin MIC=2 µg/mL) from the health-care worker's anterior nares.
Lessons from the History of Quarantine, from Plague to Influenza A
Length: 23:11





